Patents
Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
01/2004
01/15/2004US20040010022 2-aminooxazole derivatives
01/15/2004US20040009979 Use of compounds for the elevation of pyruvate dehydrogenase activity
01/15/2004US20040009877 Hetaryl-substituted heterocycles
01/15/2004CA2491573A1 Methods of treating microbial infections in humans and animals
01/15/2004CA2488816A1 Bisarylsulfonamide compounds and their use in cancer therapy
01/14/2004EP1380564A1 Binaphtol derivative and process for producing the same
01/14/2004EP1380307A1 Tissue fibrosis inhibitors
01/14/2004EP1380121A2 Process to prepare oxazolidinones
01/14/2004EP1379514A2 5-membered heterocycles, preparation and application thereof as medicaments
01/14/2004EP1379509A1 A method for the preparation of oxazolidinones
01/14/2004EP1379508A2 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof
01/14/2004EP1379498A1 Sulphones which modulate the action of gamma secretase
01/14/2004EP1379246A1 Nociceptin analogs
01/14/2004EP1019385B1 Aminoaryl oxazolidinone n-oxides
01/14/2004CN1134423C Adhesion receptor antagonists
01/14/2004CN1134422C Optically active bisoxazoline compounds, preparation method and uses thereof
01/14/2004CN1134411C Bicyclic amino derivatives and PGD2 antagonist containing same
01/13/2004US6677382 Halogenated oxyamines, used as enzyme inhibitors for prophylaxis of atherosclerosis and cardiovascular disorders, and as antilipemic agents
01/13/2004US6677380 Antilipemic agents such as 3(3-(4-chloro-3-ethyl-phenoxy)-phenyl)((3-(1,1,2,2 -tetrafluoroethoxy)phenyl)methyl))amino)-1,1,1-trifluro-2-propanthiol, used for prophlaxis of cardiovascular disorders and atherosclerosis
01/13/2004US6677379 Such as 3-((3-(3-trifluoromethoxyphenoxy)phenyl)((3-(1,1,2,2-tetrafluoroethoxy) -phenyl)methyl) amino)-1,1,1-trifluoro-2-propanol for treatment of coronary artery disease
01/13/2004US6677375 Substituted N,N-bis-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
01/13/2004US6677365 Antagonists of MCP-1 function and methods of use thereof
01/13/2004US6677360 Biphenyl and biphenyl-analogous compounds as integrin antagonists
01/13/2004US6677353 Substituted N-phenyl-N-heteroaralkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
01/13/2004US6677334 Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof
01/08/2004WO2004003103A1 Polymerizable, luminescent compounds and mixtures, luminescent polymer materials and their use
01/08/2004WO2004002977A1 Inhibitors of hcv ns5b polymerase
01/08/2004WO2004002967A1 Difluorothioacetamides of oxazolidinones as antibacterial agents
01/08/2004WO2004002943A1 4-(3,3-dihalo-allyloxy)phenoxy alkyl derivatives
01/08/2004WO2004002925A2 Process for preparing (r)-aryloxypropionic acid ester derivatives
01/08/2004WO2004002491A1 Morpholine and tetrahydropyran drivatives and their use as cathepsin inhibitors
01/08/2004WO2004002479A1 Glycoloyl-substituted oxazolidinone-derivatives as antibacterial agents
01/08/2004WO2003077828A3 Novel florfenicol-type antibiotics
01/08/2004US20040006238 As chemical intermediates for production of pharmacologically useful oxazolidinones
01/08/2004US20040006116 For therapy of non-insulin dependent diabetes mellitus
01/08/2004US20040006104 For therapy and prophylaxis of diseases and conditions associated with undesirable or abnormal inflammatory responses, such as ischemia-reperfusion injury, asthma, arthritis
01/08/2004US20040006100 Administering phenylacetic acid derivative for therapy of Parkinson's disease
01/08/2004US20040006056 Substituted alkanoic acids
01/08/2004US20040005256 Atomizing the first solution; introducing the atomized solution into the second solution; and mixing the atomized solution and the second solution to form the product.
01/08/2004CA2490193A1 Glycoloyl-substituted oxazolidinone-derivatives as antibacterial agents
01/08/2004CA2489433A1 Inhibitors of hcv ns5b polymerase
01/08/2004CA2489411A1 Difluorothioacetamides of oxazolidinones as antibacterial agents
01/08/2004CA2488525A1 Morpholine and tetrahydropyran derivatives and their use as cathepsin inhibitors
01/07/2004CN1466580A Thiazole or oxazole derivatives
01/06/2004US6673927 Farnesyl transferase inhibitors
01/02/2004EP1375499A1 Process for the production of 2-(5-methyl-4-oxazolyl)ethanol derivatives
01/02/2004EP1375474A2 Intermediate for the preparation of carvedilol
01/02/2004EP1373264A1 3-heterocyclylpropanohydroxamic acid as procollagen c-proteinase inhibitors
01/02/2004EP1373231A1 3-heterocyclylpropanohydroxamic acid pcp inhibitors
01/02/2004EP1373230A2 Enantioselective synthesis of azetidinone intermediate compounds
01/02/2004EP1373170A1 Cross-metathesis reaction of functionalized and substituted olefins using group 8 transition metal carbene complexes as metathesis catalysts
01/02/2004EP1027339B1 Method and reagents for n-alkylating ureides
01/01/2004US20040002539 Enzyme inhibitors; anticoagulants; blood collecting device
01/01/2004US20040002525 Obesity; osteoporosis
01/01/2004US20040002493 Benzoic acid derivatives and pharmaceutical agents comprising the same as active ingredient
01/01/2004US20040001970 Organic electroluminescent materials and devices made from such materials
12/2003
12/31/2003WO2004001059A2 Heterocyclic inhibitors of kinases
12/31/2003WO2004000838A1 Peptidic compounds as cysteine protease inhibitors
12/31/2003WO2004000821A1 Process for preparing 5-(1, 3-oxazol-2-yl) benzoic acid derivatives
12/31/2003WO2004000816A1 Androgen receptor agonist
12/31/2003WO2004000788A1 Ureido-substituted aniline compounds useful as serine protease inhibitors
12/31/2003WO2004000256A1 Benzoxazole and benzodiazole uv-a sunscreens
12/31/2003WO2004000214A2 Use of compounds having an amine nucleus in manufacture of a medicament useful for treating factor viia-associated conditions
12/31/2003WO2003088959A3 Treatment of parkinson's disease with cyclooxygenase-2 (cox 2) inhibitor(s)
12/31/2003WO2003073979A3 Derivatives of azaspiro compounds for the treatment of pain
12/31/2003WO2003063576A3 Arylsulfonamidobenzylic compounds
12/31/2003CA2489988A1 Process for preparing 5-(1,3-oxazol-2-yl) benzoic acid derivatives
12/30/2003US6670447 Amino acid N-carboxyanhydrides with acyl substituents on nitrogen atoms thereof
12/30/2003US6670358 Substituted thioacetamides
12/25/2003US20030236294 Anticancer agents
12/25/2003US20030236290 Inhibitors of animal cell motility and growth
12/25/2003US20030236274 Naphthalene derivatives, their production and use
12/25/2003US20030236252 Brain disorders, cardiovascular disorders, strokes, Parkinson's disease
12/25/2003US20030236250 Antidepressants, anxiolytic agents, analgesics, antiinflammatory agents, reduce concentration of tachykinins
12/25/2003US20030235853 Solid phase synthesis; for drug screening
12/24/2003WO2003106610A1 Use of transition metal complexes with nitrogen-containing polydentate ligands as a bleaching catalyst and bleaching agent composition
12/24/2003WO2003106456A2 New compounds
12/24/2003WO2003106437A1 2-oxazolidinones and their use as inhibitors of animal cell motility and growth
12/24/2003WO2003106434A1 Process for producing pyrimidine compound
12/24/2003WO2003106419A1 Room-temperature molten salt, process for producing the same and applications thereof
12/24/2003WO2003106413A2 Process for the preparation of oxazolidinones and method of use thereof
12/24/2003WO2003106405A1 Aspartyl protease inhibitors
12/24/2003WO2003093247A3 Antibacterial agents
12/24/2003CN1463268A Process for prepn. of mesylates of piperzine derivatives
12/24/2003CN1463266A Binaphthol derivative and method for producing same
12/24/2003CA2493874A1 Use of transition metal complexes with nitrogen-containing polydentate ligands as a bleaching catalyst and bleaching agent composition
12/24/2003CA2489095A1 Aspartyl protease inhibitors
12/24/2003CA2464109A1 Process for the preparation of oxazolidinones and method of use thereof
12/23/2003US6667404 Retroviral protease inhibiting compounds
12/23/2003US6667308 Compounds for use as antidepressants, aphrodisiacs and adjunctive therapies in humans
12/23/2003US6667307 HIV protease
12/23/2003CA2116387C Oxazolidinedione derivatives, their production and use
12/18/2003WO2003104230A1 Bicyclic pyrimidine derivatives
12/18/2003WO2003104203A1 Therapeutic molecules and methods-1
12/18/2003WO2003103599A2 Caspase-1 inhibitors and methods for their use
12/18/2003WO2003103598A2 Amidine derivatives for treating amyloidosis
12/18/2003WO2003074504A3 Process and intermediates for preparing phenylthiomethyl-thiazoles or oxazoles
12/18/2003US20030232997 Preparation of an aromatic bisoxazoline
12/18/2003US20030232864 Novel Compounds and compositions as protease inhibitors
12/18/2003US20030232863 Cathepsin cysteine protease inhibitors